Sellwin Traders Limited reported a net profit of ₹291.89 lakh for the financial year ended March 31, 2026, an increase from ₹244.11 lakh in the previous year. The company's board approved the standalone and consolidated audited financial results for the year at a meeting held on May 30, 2026. For the quarter ended March 31, 2026, the company recorded a net profit of ₹61.30 lakh, recovering from a net loss of ₹328.57 lakh in the quarter ended December 31, 2025, which was impacted by a provision for doubtful advances.

The statutory auditors, Parth R Shah and Co., issued an unmodified audit opinion on the financial results. The financial statements were prepared in accordance with the Companies (Indian Accounting Standard) Rules, 2015. The company operates primarily in the trading segment, which remains its only reportable segment under Ind-AS 108.

Standalone Financial Performance

For the year ended March 31, 2026, the company reported a total income of ₹4697.62 lakh, compared to ₹4415.99 lakh in the previous year. Total expenses for the year rose to ₹4345.04 lakh from ₹4078.65 lakh. Profit before tax for the year stood at ₹352.58 lakh, up from ₹337.34 lakh in FY25.

In the quarter ended March 31, 2026, total income was ₹1476.69 lakh, while total expenses were ₹1415.39 lakh, resulting in a profit of ₹61.30 lakh. This compares to a loss of ₹328.57 lakh in the preceding quarter ended December 31, 2025, where expenses had surged due to a provision of approximately ₹399.48 lakh under other expenses.

Consolidated Financial Performance

On a consolidated basis, the company reported a net profit of ₹315.09 lakh for FY26, up from ₹279.17 lakh in FY25. Total income for the year increased to ₹7863.37 lakh from ₹7434.86 lakh in the previous year. For the quarter ended March 31, 2026, the consolidated net profit was ₹51.63 lakh, compared to a net loss of ₹322.94 lakh in the quarter ended December 31, 2025.

The consolidated results include the performance of subsidiaries: Mannibhadra Aggro Private Limited, Patel & Patel E-Commerce & Services Private Limited, SDF Productions Pvt. Ltd., and Damask Jewellery Private Limited.

Sellwin Traders Limited has successfully completed the conversion of 1,01,54,056 warrants into equity shares following its board meeting held on May 2, 2026. The meeting, which took place at the company's corporate office located at 401, Sun Orbit, Rajpath Rangoli Road, Beside Pandit Din Dayal Upadhyay Auditorium, Bodakdev, Ahmedabad-380054, commenced at 01:30 P.M. and concluded at 02:00 P.M.

Warrant Conversion Details

The board approved the conversion of warrants into an equal number of equity shares with a face value of Rs. 2/- each. The conversion was executed through preferential allotment to 46 allottees who exercised their conversion rights. The equity shares were allotted at a price of Rs. 8.40/- per share, comprising Rs. 2.1/- received at the time of warrant allotment and Rs. 6.3/- received upon conversion.

Post-Allotment Capital Structure

Pursuant to the conversion, the Issued, Subscribed and Paid-up Equity Share Capital of the company stands increased to Rs. 49,00,23,112/-, consisting of 24,50,11,556 fully paid-up equity shares of Rs. 2/- each. The newly allotted equity shares rank pari-pasu with the existing equity shares of the company.

Key Allottees

The preferential allotment was made to 46 investors, including prominent entities such as Mideast Healthcare Private Limited, which received 4,000,000 shares representing 1.63% of the post-issue shareholding, and Rupaben Jayeshbhai Raval, who received 1,224,337 shares representing 0.50% holding. Other significant allottees included Surbhiben Satishkumar Desai (625,000 shares, 0.26%), Paras Mahendrabhai Shah (500,000 shares, 0.20%), and Madiya Roshni Deepeskumar (250,000 shares, 0.10%).

Company Information

Sellwin Traders Limited operates with its registered office at 126/B Old China Bazar Street, Kolkata 700001, and maintains its corporate office in Ahmedabad. Pratiti Patel, Company Secretary and Compliance Officer (Membership No.: A63826), signed the regulatory filings on behalf of the company. The warrant holders were entitled to exercise their conversion rights within 18 months from the date of warrant allotment, in accordance with SEBI (ICDR) Regulations.